Maintenance fees coming due
36 maintenance fees come due in the 12 months from Nov 17, 2026, the next on Dec 6, 2026. Unpaid by Jun 7, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5
and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the
six month grace period that follows.
| Patent | Title | Holder | Status | Fee due | Lapses if unpaid | Expires | Confidence |
|---|---|---|---|---|---|---|---|
| US 11,667,632 | 2-(1H-Indazol-3-yl)-3H-imidazo[4,5-c]pyridines and Their Anti-Inflammatory Uses Thereof In force Fee due Dec 6, 2026 Lapses if unpaid Jun 7, 2027 · High confidence | Biosplice Therapeutics, Inc. | In force | Dec 6, 2026 | Jun 7, 2027 | High confidence | |
| US 10,314,832 | B- AND y -DIKETONES AND y -HYDROXYKETONES AS WNT/ B -CATENIN SIGNALING PATHWAY ACTIVATORS In force Fee due Dec 11, 2026 Lapses if unpaid Jun 11, 2027 · High confidence | Biosplice Therapeutics, Inc. | In force | Dec 11, 2026 | Jun 11, 2027 | High confidence | |
| US 11,673,881 | ISOQUINOLIN-3-YL Carboxamides and Preparation and Use Thereof In force Fee due Dec 13, 2026 Lapses if unpaid Jun 14, 2027 · High confidence | Biosplice Therapeutics, Inc. | In force | Dec 13, 2026 | Jun 14, 2027 | High confidence | |
| US 11,673,885 | Gamma-Diketones as Wnt/Beta -Catenin Signaling Pathway Activators In force Fee due Dec 13, 2026 Lapses if unpaid Jun 14, 2027 · High confidence | Biosplice Therapeutics, Inc. | In force | Dec 13, 2026 | Jun 14, 2027 | High confidence | |
| US 10,329,309 | 3-(3H-Imidazo[4,5-b]pyridin-2-yl)-1H-pyrazolo[4,3-b] Pyridines and Therapeutic Uses Thereof In force Fee due Dec 25, 2026 Lapses if unpaid Jun 25, 2027 · High confidence | Biosplice Therapeutics, Inc. | In force | Dec 25, 2026 | Jun 25, 2027 | High confidence | |
| US 11,684,615 | Methods of Using INDAZOLE-3-Carboxamides and Their Use as Wnt/B-Catenin Signaling Pathway Inhibitors In force Fee due Dec 27, 2026 Lapses if unpaid Jun 28, 2027 · High confidence | Biosplice Therapeutics, Inc. | In force | Dec 27, 2026 | Jun 28, 2027 | High confidence | |
| US 9,067,939 | 1H-Pyrazolo[3,4-b]pyridines and Therapeutic Uses Thereof In force Fee due Dec 30, 2026 Lapses if unpaid Jun 30, 2027 · High confidence | Biosplice Therapeutics, Inc. | In force | Dec 30, 2026 | Jun 30, 2027 | High confidence | |
| US 10,342,788 | 1H-Pyrazolo[3,4-b]pyridines and Therapeutic Uses Thereof In force Fee due Jan 9, 2027 Lapses if unpaid Jul 9, 2027 · High confidence | Biosplice Therapeutics, Inc. | In force | Jan 9, 2027 | Jul 9, 2027 | High confidence | |
| US 10,350,199 | 3-(1H-Pyrrolo[2,3-b]pyridin-2-yl)-1H-indazoles and Therapeutic Uses Thereof In force Fee due Jan 16, 2027 Lapses if unpaid Jul 16, 2027 · High confidence | Biosplice Therapeutics, Inc. | In force | Jan 16, 2027 | Jul 16, 2027 | High confidence | |
| US 9,090,613 | Indazole Inhibitors of the WNT Signal Pathway and Therapeutic Uses Thereof In force Fee due Jan 28, 2027 Lapses if unpaid Jul 28, 2027 · High confidence | Biosplice Therapeutics, Inc. | In force | Jan 28, 2027 | Jul 28, 2027 | High confidence | |
| 26 more maintenance fees coming due in the 12 months from Nov 17, 2026 · Pro | |||||||
10 of 36 patents shown. Soonest fee due date first, then patent number.
Pro members see every patent with a maintenance fee coming due: number, title, status, the due date, and the date it lapses if the fee goes unpaid through the grace period.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.